March 29th 2023
Among persons with prediabetes who reverted to normoglycemia, only those who remained physically active saw a reduced risk of all-cause death, study authors report.
March 27th 2023
Urban Areas in US are Associated with Lower Rates of Hypertension Medication Adherence, New Study FindsSeptember 13th 2022
AHA Hypertension 2022: New research showed that hypertension medication adherence was nearly 76% in large urban areas and increased as population density decreased.
Early-onset Type 2 Diabetes Linked to Significantly Increased Risk for CVD in Later Life: StudySeptember 13th 2022
A 5-fold greater risk for all-cause or CVD-related death in persons diagnosed with T2D before age 40 years should be a call to action for enhanced screening, study authors state.
Hypertension Treatment is Cost-effective for CVD Prevention, Whether the Target is from ACC/AHA or JNC 7, Study RevealsSeptember 9th 2022
Reducing blood pressure to 140/90 mm Hg or 130/80 mm Hg in high-risk patients proved either cost-saving or cost-effective at 10 years in a simulation study.
DASH Diet May Prevent Nearly 27 000 US CVD Events in Patients with Stage 1 Hypertension, According to Simulation StudySeptember 8th 2022
AHA Hypertension 2022: Adoption of the DASH diet was found to prevent an estimated 16 000 CVD events among men and 11 000 among women with untreated stage 1 HTN.